Significant Ownership of Lara Sullivan

Signature - Title
/s/ Lara Sullivan - Lara Sullivan, President,Chief Executive Officer & Chief Medical Officer
Location
Rockville, MD
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Lara Sullivan.

Follow Filing Activity

Follow Lara Sullivan and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Significant Ownership of Lara Sullivan

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PYXS Pyxis Oncology, Inc. Common Stock, par value $0.001 per share 11% $7,844,727 +$955,040 7,543,007 +14% Lara Sullivan, M.D. 31 Mar 2025

Schedules 13D/G Reported by Lara Sullivan:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .